Kensington Labs vs KÖLD Peptides
Kensington Labs and KÖLD Peptides have near-identical PepFinder Scores (6.4 and 6.5). Both list 16 of the same peptides. Neither can pay to change the comparison.
 Kensington LabsVisit store | KÖLD PeptidesVisit store | |
|---|---|---|
| PepFinder Score | 6.4 | 6.5 |
| Trustpilot | No score found | No score found |
| Customer rating | No reviews yet | No reviews yet |
| Would order again | Needs 5+ reviews | Needs 5+ reviews |
| Product selection | 8.4/10 24 peptides · 40 products | 7.7/10 17 peptides · 21 products |
| Pricing and value | 5.8/10 3% more expensive than average per mg | 4.1/10 40% more expensive than average per mg |
| Delivery | Not rated yet | Not rated yet |
| Payment options | 8.5/10 Bank transferCardApple PayGoogle Pay | Not rated yet None found |
| Customer support | 5.0/10 None found yet | Not rated yet None found yet |
| Website experience | Not rated yet | Not rated yet |
| Reliability | 5.5/10 | 7.5/10 |
| Packaging | Not rated yet | Not rated yet |
| Ships from | Not stated | Not stated |
| Ships to | Not stated | United States |
| Median price per mg | £3.99 | US$7.75 |
The shaded cell is the higher rating in that row. Each rating's source (automated data, customer reviews or editorial) is shown on the supplier's profile.
Testing & transparency (optional detail)
| Kensington Labs | KÖLD Peptides | |
|---|---|---|
| Transparency Score | 3.5Provisional | 3.7Provisional |
| Testing transparency | 4.6 | 4.6 |
| Company transparency | 2.7 | 3.3 |
| Documentation | 2.8 | 2.4 |
| Third-party testing stated | ✓ Yes | ✓ Yes |
| Publishes COAs | ✓ Yes | ✓ Yes |
| Batch-specific COAs | Not yet assessed | Not yet assessed |
| COAs reviewed by us | 0 | 0 |
| Verification | Not verified | Not verified |
| Company registration | Not published | Not published |
| Years tracked | 0.0 | 0.0 |
| Refund policy clear | Not yet assessed | Not yet assessed |
Full profiles: Kensington Labs · KÖLD Peptides · add more suppliers
Supplier and market information only; not medical advice.